Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 1.744
+0.096 (5.83%)
Jul 16, 2025, 5:23 PM CET
Alzinova AB Revenue
Alzinova AB had revenue of 6.09M SEK in the quarter ending March 31, 2025, with 113.60% growth. This brings the company's revenue in the last twelve months to 20.05M, up 11.06% year-over-year. In the year 2024, Alzinova AB had annual revenue of 16.81M, down -15.41%.
Revenue (ttm)
20.05M
Revenue Growth
+11.06%
P/S Ratio
8.57
Revenue / Employee
4.01M
Employees
5
Market Cap
171.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.81M | -3.06M | -15.41% |
| Dec 31, 2023 | 19.87M | 3.24M | 19.49% |
| Dec 31, 2022 | 16.63M | -688.74K | -3.98% |
| Dec 31, 2021 | 17.32M | 2.42M | 16.27% |
| Dec 31, 2020 | 14.90M | 8.09M | 118.80% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |